Glaxo Changes How It Pays Sales Reps as Drugmaker Bets on Cancer

(Bloomberg) -- GlaxoSmithKline Plc has reversed course on how it pays some of its sales representatives in a bid to spur growth as the U.K. drugmaker expands in the competitive market for cancer me...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.